Kaya Holdings, Inc.
CIK 1530746fmd_19EGVDCEH2PDW7JE4G53YXF6CCManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2008 to Sep 30, 2025, 62 periods
| Line item | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | – | – | – | – | 1 | 1 | 1 | 1 | 0 | 0 |
| Cost of revenue | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross profit | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | (0) |
| Selling, general and administrative | – | – | – | – | – | – | – | – | – | – |
| Total operating expenses | 2 | 2 | 3 | 4 | 3 | 3 | 2 | 2 | 1 | 2 |
| Operating income | (2) | (2) | (2) | (3) | (2) | (2) | (1) | (2) | (1) | (2) |
| Interest expense | 0 | 0 | 0 | 1 | 1 | 1 | 1 | – | – | – |
| Other non-operating income (expense) | – | – | – | 0 | – | (10) | 12 | (2) | 3 | (0) |
| Income tax expense | – | – | – | – | – | 0 | 0 | 0 | 0 | – |
| Net income from continuing operations | – | – | – | – | – | – | – | – | 1 | (2) |
| Net income | (3) | (20) | (15) | 5 | 8 | (12) | 10 | (4) | 2 | (2) |
| Net income to common shareholders | – | – | – | – | – | 12 | 10 | (4) | 2 | (2) |